Imunon, Inc. Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable
Imunon, Inc. (IMNN) had Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable of 405.07 thousand shares as of 2017-12-31, per its 10-K filed 2018-03-27.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions · last filed 2018-03-27
- 2017-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 405.07K shares.
- 2016-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 2.20M shares.
- 2015-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 1.32M shares.
- 2014-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 990.94K shares.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable |
|---|---|
| 2017-12-31 | 405.07K shares 10-K · filed 2018-03-27 |
| 2016-12-31 | 2.20M shares 10-K · filed 2017-03-24 |
| 2015-12-31 | 1.32M shares 10-K · filed 2016-03-30 |
| 2014-12-31 | 990.94K shares 10-K · filed 2015-03-12 |
| 2013-12-31 | 601.48K shares 10-K · filed 2014-03-13 |
| 2012-12-31 | 1.91M shares 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |